Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 19 April 1985:
Vol. 228. no. 4697, pp. 337 - 339
DOI: 10.1126/science.3885394

Articles

Science, Vol 228, Issue 4697, 337-339
Copyright © 1985 by American Association for the Advancement of Science


articles

Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes

PM Colombani, A Robb, and AD Hess

Cyclosporin A, a potent immunosuppressive agent, has been widely used to treat patients with solid organ transplants. Although its precise mechanism of action is unknown, it appears to inhibit subsets of T lymphocytes at an early stage in cell activation. Fluorescent, fully active derivatives of cyclosporin A and calmodulin, a protein that binds calcium and is therefore essential to normal cell function, were utilized to demonstrate that cyclosporin A binds to calmodulin. Flow cytometry showed that the calmodulin inhibitors R24571 and W-7 competitively inhibited binding of cyclosporin A to cloned T lymphocytes. Cyclosporin A inhibited the calmodulin-dependent activation of phosphodiesterase in a dose-dependent manner. Binding of cyclosporin A to calmodulin may prevent the latter's role in the activation of the second messengers and enzymes required for effective cell proliferation and function in the immune response.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Drug points: Erythromelalgia induced by possible calcium channel blockade by ciclosporin.
G. P Thami and M. Bhalla (2003)
BMJ 326, 910
   Full Text »    PDF »
Signal Transduction Mechanisms in Mesenchymal Cells.
B. S. McAllister, J. D. Walters, and M. S. Olson (1994)
Critical Reviews in Oral Biology & Medicine 5, 291-310
   Abstract »    Full Text »    PDF »
Drug-Induced Gingival Overgrowth: Old Problem, New Problem.
T. M. Hassell and A. F. Hefti (1991)
Critical Reviews in Oral Biology & Medicine 2, 103-137
   Full Text »    PDF »
Cyclosporine: An Immunosuppressant Affecting Epithelial Cell Proliferation.
J. Kanitakis and J. Thivolet (1990)
Arch Dermatol 126, 369-375
   Abstract »    PDF »
Cyclosporine Improves Psoriasis in a Double-blind Study.
C. N. Ellis, D. C. Gorsulowsky, T. A. Hamilton, J. K. Billings, M. D. Brown, J. T. Headington, K. D. Cooper, O. Baadsgaard, E. A. Duell, T. M. Annesley, et al. (1986)
JAMA 256, 3110-3116
   Abstract »    PDF »
Does the binding of cyclosporine to calmodulin result in immunosuppression?.
S. LeGrue, R Turner, N Weisbrodt, and Dedman JR (1986)
Science 234, 68-71
   Abstract »    PDF »
Dermatologic Applications of Cyclosporine.
t. A. Biren and R. J. Barr (1986)
Arch Dermatol 122, 1028-1032
   Abstract »    PDF »
Calmodulin, cyclophilin, and cyclosporin A.
W. Hait, M. Harding, and R. Handschumacher (1986)
Science 233, 987-989
   PDF »
Response: Calmodulin, Cyclophilin, and Cyclosporin A.
P. M. COLOMBANI and A. D. HESS (1986)
Science 233, 988-989
   PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)